Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 ...

The 18th PFS & Injectable Drug Devices Europe Conference returns to London next January, setting the tone for 2026 with a ...

That’s why this year’s Antifibrotic Drug Development Summit is THE place to be this November. Learn from the industry’s ...

Anti-amyloid antibody Leqembi (lecanemab) made its EU debut in Austria yesterday and will be introduced in Germany on Monday ...

It turns out that AbbVie is only interested in buying Gilgamesh's lead drug programme, a psychedelic candidate for major ...

Nucleus RadioPharma, the radiopharmaceutical-focused contract developing and manufacturing organisation founded by Eclipse ...

A new study published in the Nature journal of Mental Health Research shows powerful real-world evidence for the efficacy of ...

Despite being a rare disease impacting less than a million people worldwide, gMG treatment is an increasingly crowded market, ...

This month’s executive moves in the agency, consultancy, and investor sectors reflect a growing emphasis on strategic leadership, commercial expansion, and specialised expertise in life sciences. From ...

After UK Health Secretary Wes Streeting sent a letter to the pharma industry, warning that he would withdraw from ...

Twin Health has raised another $53 million to fund its 'digital twin' platform, which provides a model of a patient's unique ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Suzanne Aitken, SVP of managed access at Clinigen, ...